Patterns of Failure in Advanced Stage Diffuse Large B-Cell Lymphoma Patients After Complete Response to R-CHOP Immunochemotherapy and the Emerging Role of Consolidative Radiation Therapy-Reference-Cited by-同舟云学术

Patterns of Failure in Advanced Stage Diffuse Large B-Cell Lymphoma Patients After Complete Response to R-CHOP Immunochemotherapy and the Emerging Role of Consolidative Radiation Therapy

Published:2013-07 Issue:3 Volume:86 Page:569-577
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Shi Zheng,Das Satya,Okwan-Duodu Derick,Esiashvili Natia,Flowers Christopher,Chen Zhengjia,Wang Xiaojing,Jiang Kun,Nastoupil Loretta J.,Khan Mohammad K.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference20 articles.

1. Improving outcomes for patients with diffuse large B-cell lymphoma;Flowers;Cancer,2010

2. Diffuse large B-cell lymphoma: Current treatment approaches;Nastoupil;Oncology (Williston Park),2012

3. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma;Fisher;N Engl J Med,1993

4. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma;Gianni;N Engl J Med,1997

5. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: A study by the Groupe d’Etudes des Lymphomes de l’Adulte;Coiffier;Blood,2010

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of initial tumor bulk in DLBCL treated with DA-EPOCH-R vs. R-CHOP: a secondary analysis of alliance/CALGB 50303;Leukemia & Lymphoma;2024-09-05

2. Association of overall survival benefit of radiotherapy with progression-free survival after chemotherapy for diffuse large B-cell lymphoma: A systematic review and meta-analysis;Journal of the National Cancer Center;2024-09

3. Plasmablastic Lymphoma. A State-of-the-Art Review: Part 2-Focus on therapy;Mediterranean Journal of Hematology and Infectious Diseases;2024-02-29

4. Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab era;BMC Cancer;2024-01-13

5. Hypofractionated Radiotherapy for Refractory or Relapsed Aggressive B-cell Lymphoma in the Rituximab Era;2023-08-30